Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Blood glucose absorption rate" is **not a molecule, receptor, transporter, or canonical drug target**. Rather, it refers to the *physiological rate* at which glucose is absorbed from the gastrointestinal tract into the bloodstream after carbohydrate ingestion[5][3]. This process primarily involves nutrient digestion, gastric emptying, intestinal absorption via sodium/glucose cotransporter 1 (SGLT1) and glucose transporter 2 (GLUT2), as well as modulation by various digestive and endocrine hormones[2][3]. The absorption rate impacts postprandial (after-eating) blood glucose excursions and is a complex trait determined by meal composition, gut motility, transporter expression, and feedback from hormones such as insulin and incretins[3][5][8]. It is an important *physiological parameter*, especially in metabolic research (e.g. diabetes), but is **not a specific drug target, receptor, or molecule**. Therefore, it does not fit structured fields designed for molecules, receptors, or canonical drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood glucose absorption rate.